U.S. federal trademark · Serial No. 78256194 · Reg. No. 3490090
Prescription drug consulting software used for optimizing the cost-effectiveness of drug prescription plans for others, including the use of generic, formulary, and non-formulary drug alternatives; for stratifying drugs according to co-pay tiers; for optimizing a condensed list of prescription alternatives representing direct pharmaceutical equivalents and/or therapeutic equivalents to the currently prescribed medications; and identifying drugs as a recommended replacements
Business cost consulting services in the field of prescription drugs, namely, consulting services to perform an optimization routine to pre-analyze currently prescribed medication and display a best-case drug utilization scenario based on cost and evidence based medicine
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.